169 related articles for article (PubMed ID: 37681913)
21. Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression.
Wang Z; Zeng Z; Gao F; Gui Z; Du J; Shen N; Shang Y; Yang Z; Shang L; Wei R; Ma W; Wang C
BMC Med Genomics; 2023 Feb; 16(1):30. PubMed ID: 36803385
[TBL] [Abstract][Full Text] [Related]
22. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
[TBL] [Abstract][Full Text] [Related]
23. The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma.
Ying T; Dong JL; Yuan C; Li P; Guo Q
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31850493
[TBL] [Abstract][Full Text] [Related]
24. A systems biology approach reveals common metastatic pathways in osteosarcoma.
Flores RJ; Li Y; Yu A; Shen J; Rao PH; Lau SS; Vannucci M; Lau CC; Man TK
BMC Syst Biol; 2012 May; 6():50. PubMed ID: 22640921
[TBL] [Abstract][Full Text] [Related]
25. Molecular classification of osteosarcoma.
Lau CC
Cancer Treat Res; 2009; 152():459-65. PubMed ID: 20213408
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
27. Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Yuan YB; Lu XC; Zhang Y; Liu YK; Wen J; Khader MA; Liu T; Li JZ; Zhang Y
Cancer Med; 2021 Jul; 10(13):4493-4509. PubMed ID: 34047495
[TBL] [Abstract][Full Text] [Related]
28. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
29. Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: a proteomic-based research.
Xie XB; Yin JQ; Wen LL; Gao ZH; Zou CY; Wang J; Huang G; Tang QL; Colombo C; He WL; Jia Q; Shen JN
PLoS One; 2012; 7(10):e47375. PubMed ID: 23091618
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-373 Promotes Growth and Cellular Invasion in Osteosarcoma Cells by Activation of the PI3K/AKT-Rac1-JNK Pathway: The Potential Role in Spinal Osteosarcoma.
Liu Y; Cheng Z; Pan F; Yan W
Oncol Res; 2017 Jul; 25(6):989-999. PubMed ID: 28244849
[TBL] [Abstract][Full Text] [Related]
31. A panel of eight mRNA signatures improves prognosis prediction of osteosarcoma patients.
Wu B; Wang Z; Lin N; Yan X; Lv Z; Ying Z; Ye Z
Medicine (Baltimore); 2021 Apr; 100(14):e24118. PubMed ID: 33832059
[TBL] [Abstract][Full Text] [Related]
32. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
33. mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts.
Kuijjer ML; Namløs HM; Hauben EI; Machado I; Kresse SH; Serra M; Llombart-Bosch A; Hogendoorn PC; Meza-Zepeda LA; Myklebost O; Cleton-Jansen AM
BMC Med Genomics; 2011 Sep; 4():66. PubMed ID: 21933437
[TBL] [Abstract][Full Text] [Related]
34. Plasma proteomic profiling of pediatric osteosarcoma.
Li Y; Dang TA; Man TK
Methods Mol Biol; 2012; 818():81-96. PubMed ID: 22083817
[TBL] [Abstract][Full Text] [Related]
35. Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma.
Delsin LEA; Roberto GM; Fedatto PF; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Pathol Oncol Res; 2019 Jan; 25(1):11-20. PubMed ID: 28944406
[TBL] [Abstract][Full Text] [Related]
36. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Lei T; Qian H; Lei P; Hu Y
Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
[TBL] [Abstract][Full Text] [Related]
38. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
39. Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases.
Wang D; Niu X; Wang Z; Song CL; Huang Z; Chen KN; Duan J; Bai H; Xu J; Zhao J; Wang Y; Zhuo M; Xie XS; Kang X; Tian Y; Cai L; Han JF; An T; Sun Y; Gao S; Zhao J; Ying J; Wang L; He J; Wang J
Cancer Res; 2019 Jan; 79(1):7-20. PubMed ID: 30389703
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes.
Patil V; Mahalingam K
Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
